Collagen crosslinking in the management of advanced non-resolving microbial keratitis

British Journal of Ophthalmology

Volumn 98, Issue 8, 2014, Pages 1033-1035

  Shetty, Rohit ^a   Nagaraja, Harsha ^a   Jayadev, Chaitra ^a   Shivanna, Yathish ^a   Kugar, Thungappa ^a  

^a Narayana Health City   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; COLLAGEN;

ADULT; AGED; ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY; ARTICLE; BACTERIAL KERATITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLLAGEN CROSS LINKAGE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPYON; KERATITIS; KERATOMYCOSIS; KERATOPLASTY; MALE; MICROBIAL KERATITIS; MICROBIOLOGICAL EXAMINATION; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SLIT LAMP; TREATMENT RESPONSE;

CORNEA; INFECTION; INFLAMMATION; WOUND HEALING;

ADULT; AGED; CROSS-LINKING REAGENTS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; KERATITIS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET THERAPY;

EID: 84905080242     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-304944     Document Type: Article

References (20)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214-21. (Pubitemid 32246479)
2. Burd EM, Ogawa GSH, Hyndiuk RA. Bacterial keratitis and conjunctivitis. In: Smolin G, Thoft RA, eds. The cornea scienti fic foundations and clinical practice. 3rd edn. Boston: Little, Brown, & Co, 1994:115-67.
3. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology 2006;113:109-16. (Pubitemid 43021736)
4. Wong T, Ormonde S, Gamble G, et al. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003;87:1103-8. (Pubitemid 37064885)
5. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology 1981;88:814-20. (Pubitemid 11039470)
6. Bertino J S. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 2009;3:507-21.
7. Goodrich RP. The use of riboflavin for inactivation of pathogens in blood products. Vox Sang 2000;78:211-15.
8. McAteer MJ, Tay-Goodrich B, Doane S. Photoinactivation of virus in packed red blood cell units using riboflavin and visible light. Transfusion 2000;3(Suppl):99S.
9. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 2008;49:3402-8.
10. Schrier A, Greebel G, Attia H, et al. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg 2009;25:S799-802.
11. Makdoumi K, Backman A, Mortensen J, et al. Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol 2010;248:207-12.
12. Shi W, Liu M, Gao H, et al. Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment. Graefes Arch Clin Exp Ophthalmol 2009;247:1383-8.
13. Tsugita A, Okada Y, Uchara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta 1965;103:360-3.
14. Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 2011;5:1277-80.
15. Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea 2010;29:1353-8.
16. Morén H, Malmsjö M, Mortensen J, et al. Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 2010;29:102-4.
17. Iseli HP, Thiel MA, Hafezi F, et al. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 2008;27:590-4.
18. Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 2011;118:324-31.
19. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 2008;49:3402-8.
20. Price MO, Tenkman LR, Schrier A, et al. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 2012;28:706-13.